Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cells-Reference-Cited by-同舟云学术

Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cells

Published:2020-08 Issue: Volume:128 Page:110330
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Tange Naoyuki,Hayakawa Fumihiko,Yasuda Takahiko,Odaira Koya,Yamamoto Hideyuki,Hirano Daiki,Sakai Toshiyasu,Terakura Seitaro,Tsuzuki Shinobu,Kiyoi Hitoshi

Funder

Astellas Pharma Inc.

Bristol-Myers Squibb

Chugai Pharmaceutical Co., Ltd.

Daiichi Sankyo Co., Ltd

Eisai Co., Ltd.

FUJIFILM Corporation

Kyowa-Hakko Kirin Co., Ltd

Nippon Shinyaku Co., Ltd.

Otsuka Pharmaceutical Co., Ltd.

Perseus Proteomics Inc.

Takeda Pharmaceutical Co., Ltd.

Sumitomo Dainippon Parma Co., Ltd.

Zenyaku Kogyo Co., Ltd.

honoraria

JSPS KAKENHI

Grants for Practical Research for Innovative Cancer Control

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference30 articles.

1. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors;Molkentin;Proc. Natl. Acad. Sci. U. S. A.,1996

2. MEF2: a calcium-dependent regulator of cell division, differentiation and death;McKinsey;Trends Biochem. Sci.,2002

3. MEF2: a central regulator of diverse developmental programs;Potthoff;Development,2007

4. Essential control of early B-cell development by Mef2 transcription factors;Herglotz;Blood,2016

5. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes;Ma;Cancer Res.,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Driving the degradation of oncofusion proteins for targeted cancer therapy;Drug Discovery Today;2023-06

2. Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children;International Journal of Molecular Sciences;2022-03-02

3. Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia;Journal of Clinical Medicine;2021-08-25

4. Preventive Healthcare and Management for Acute Lymphoblastic Leukaemia in Adults: Case Report and Literature Review;Healthcare;2021-05-02

5. Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia;Frontiers of Medicine;2021-01-05